Goniothalamus yunnanensis
Goniothalamus yunnanensis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Goniothalamus yunnanensis is a distinctive botanical species that has recently garnered significant attention within the field of pharmacological research. Scientific investigations have identified that the plant's leaf contains a potent bioactive compound known as Griffithazanone A. This specific chemical constituent is being rigorously studied for its potential therapeutic efficacy against various malignant growths. Most notably, current research focuses on its ability to combat the progression of Non-Small Cell Lung Cancer. Understanding these molecular interactions offers promising new pathways for the development of targeted cancer treatments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Annonaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Goniothalamus yunnanensis is a distinctive plant species recognized by its traditional Chinese name, 云南哥纳香. This botanical specimen belongs to a unique genus that often captures the interest of researchers studying tropical flora. By connecting its scientific classification to its local nomenclature, one can better understand its cultural and regional significance. The relationship between its formal identity and its common name highlights the deep integration of such plants into local knowledge systems. Exploring these linguistic links provides a more holistic view of the plant's role within its natural environment.
Sources: Catalogue of Life (COL)
Taxonomy
Goniothalamus yunnanensis is a distinct biological entity belonging to the kingdom Plantae. This species is classified under the class Equisetopsida and falls within the order Magnoliales. Within this botanical framework, it is a member of the diverse family Annonaceae. It is further identified by its specific placement in the genus Goniothalamus. Through these classifications, scientists can better understand its evolutionary position and unique characteristics.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Magnoliales |
| Family | Annonaceae |
| Genus | Goniothalamus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Goniothalamus yunnanensis is a distinctive plant species with a broad geographic reach across several regions. Its presence is noted within the temperate zones of Asia, specifically throughout various parts of China and the South-Central provinces. Additionally, the species extends its range into tropical Asian environments. This tropical distribution includes the Indo-China region as well as the lush landscapes of Vietnam. Consequently, the plant thrives in diverse climates ranging from temperate forests to tropical jungles.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Goniothalamus yunnanensis is a self-supporting plant that grows in a distinctive shrub form. Reaching a maximum height of 4 meters, it establishes a sturdy presence within its natural habitat. This structural development allows the species to thrive effectively in its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Goniothalamus yunnanensis serves as a significant natural source for the discovery of potent anti-tumor compounds. Researchers successfully isolated several alkaloids and styryllactones from the twigs and leaves of this plant, including the notable compound griffithazanone A. This specific molecule has demonstrated strong inhibitory activity against non-small cell lung cancer cells by inducing apoptosis and generating reactive oxygen species. Furthermore, griffithazanone A works by targeting PIM1, which helps regulate critical protein pathways involved in cell death. Most importantly, the compound enhances the efficacy of existing EGFR-targeted drugs and can even reverse resistance to treatments like osimertinib.
Conditions
Goniothalamus yunnanensis contains natural compounds that demonstrate significant potential in treating non-small cell lung cancer (NSCLC). Specifically, the isolated compound griffithazanone A exhibits strong inhibitory activity against A549 lung cancer cells by inducing apoptosis and cytotoxicity. This plant-derived substance works by targeting the PIM1 protein and regulating key apoptosis-related protein pathways. Furthermore, griffithazanone A serves as a sensitizer that enhances the efficacy of EGFR-targeted drugs like gefitinib and osimertinib. By reversing resistance to these common treatments, the components of Goniothalamus yunnanensis offer a promising therapeutic strategy for managing NSCLC.
Preparations
Parts used
Goniothalamus yunnanensis serves as a significant source of natural compounds for potential anti-tumor drug development. Researchers have successfully isolated several alkaloids and styryllactones from the twigs and leaves of this specific plant. Among these isolated substances, griffithazanone A has demonstrated remarkable inhibitory activity against non-small cell lung cancer cells. This compound works by inducing apoptosis and regulating key protein pathways to combat cancer progression. Ultimately, the study suggests that components derived from the leaves of this plant could help reverse resistance to existing EGFR-targeted therapies.